Cargando…

Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion

MCs (mast cells) adversely affect atherosclerosis by promoting the progression of lesions and plaque destabilization. MC chymase cleaves apoA-I (apolipoprotein A-I), the main protein component of HDL (high-density lipoprotein). We previously showed that C-terminally truncated apoA-I (cleaved at the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Usami, Yoko, Kobayashi, Yukihiro, Kameda, Takahiro, Miyazaki, Akari, Matsuda, Kazuyuki, Sugano, Mitsutoshi, Kawasaki, Kenji, Kurihara, Yuriko, Kasama, Takeshi, Tozuka, Minoru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2012
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522476/ https://www.ncbi.nlm.nih.gov/pubmed/23072735 http://dx.doi.org/10.1042/BSR20120094

Ejemplares similares

Effects of Myeloperoxidase-Induced Oxidation on Antiatherogenic Functions of High-Density Lipoprotein
por: Kameda, Takahiro, et al.
Publicado: (2015)

Highly oxidized low-density lipoprotein does not facilitate platelet aggregation
por: Miyazaki, Akari, et al.
Publicado: (2020)

Disruption in the balance between apolipoprotein A‐I and mast cell chymase in chronic hypersensitivity pneumonitis
por: Inoue, Yukihisa, et al.
Publicado: (2020)

The combined action of mast cell chymase, tryptase and carboxypeptidase A3 protects against melanoma colonization of the lung
por: Grujic, Mirjana, et al.
Publicado: (2017)

Cholesterol Efflux Capacity of Apolipoprotein A-I Varies with the Extent of Differentiation and Foam Cell Formation of THP-1 Cells
por: Yano, Kouji, et al.
Publicado: (2016)

Usefulness of apolipoprotein B-depleted serum in cholesterol efflux capacity assays using immobilized liposome-bound gel beads
por: Horiuchi, Yuna, et al.
Publicado: (2019)

CARBOXYPEPTIDASE : III. THE ESTIMATION OF CARBOXYPEPTIDASE AND PRO-CARBOXYPEPTIDASE
por: Anson, M. L.
Publicado: (1937)

Chymase Activities and Survival in Endotoxin-Induced Human Chymase Transgenic Mice
por: Rafiq, Kazi, et al.
Publicado: (2014)

CARBOXYPEPTIDASE : I. THE PREPARATION OF CRYSTALLINE CARBOXYPEPTIDASE
por: Anson, M. L.
Publicado: (1937)

CARBOXYPEPTIDASE : II. THE PARTIAL PURIFICATION OF PRO-CARBOXYPEPTIDASE
por: Anson, M. L.
Publicado: (1937)

Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties
por: Nguyen, Su Duy, et al.
Publicado: (2016)

Cut-off values of serum IgG4 among three reagents, including a novel IgG4 reagent: a multicenter study
por: Usami, Yoko, et al.
Publicado: (2021)

Mast Cell Chymase and Kidney Disease
por: Vibhushan, Shamila, et al.
Publicado: (2020)

A New High-Speed Droplet-Real-Time Polymerase Chain Reaction Method Can Detect Bovine Respiratory Syncytial Virus in Less than 10 Min
por: UEHARA, Masayuki, et al.
Publicado: (2013)

Comparison of a novel cholesterol efflux assay using immobilized liposome-bound gel beads with the conventional method
por: Horiuchi, Yuna, et al.
Publicado: (2020)

Development of free 25-hydroxyvitamin D(3) assay method using liquid chromatography-tandem mass spectrometry
por: Ishimine, Nau, et al.
Publicado: (2022)

Role of chymase in the local renin-angiotensin system in keloids: inhibition of chymase may be an effective therapeutic approach to treat keloids
por: Wang, Ru, et al.
Publicado: (2015)

Development and validation of novel automatable assay for cholesterol efflux capacity
por: Mutsuda, Yume, et al.
Publicado: (2023)

Mutations in Arg143 and Lys192 of the Human Mast Cell Chymase Markedly Affect the Activity of Five Potent Human Chymase Inhibitors
por: Ahooghalandari, Parvin, et al.
Publicado: (2013)

Glycation of HDL Polymerizes Apolipoprotein M and Attenuates Its Capacity to Bind to Sphingosine 1-Phosphate
por: Kobayashi, Tamaki, et al.
Publicado: (2021)

Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice
por: Terai, Kentaro, et al.
Publicado: (2020)

Chymase inhibition retards albuminuria in type 2 diabetes
por: Bivona, Benjamin J., et al.
Publicado: (2019)

Chymase as a Novel Therapeutic Target in Acute Pancreatitis
por: Kuramoto, Toru, et al.
Publicado: (2021)

Pathophysiological Role of Chymase-Activated Matrix Metalloproteinase-9
por: Takai, Shinji, et al.
Publicado: (2022)

A Novel Mutation in the Fibrinogen Bβ Chain (c.490G>A; End of Exon 3) Causes a Splicing Abnormality and Ultimately Leads to Congenital Hypofibrinogenemia
por: Taira, Chiaki, et al.
Publicado: (2017)

Apolipoprotein: prospective biomarkers in digestive tract cancer
por: Zhang, Yibo, et al.
Publicado: (2020)

Effects of mitomycin C on the expression of chymase and mast cells in the conjunctival scar of a monkey trabeculectomy model
por: Okada, Kouhei, et al.
Publicado: (2009)

Involvement of mast cell chymase in burn wound healing in hamsters
por: DONG, XIANGLIN, et al.
Publicado: (2013)

The Role of Mast Cell Specific Chymases and Tryptases in Tumor Angiogenesis
por: de Souza Junior, Devandir Antonio, et al.
Publicado: (2015)

Japanese encephalitis virus neuropenetrance is driven by mast cell chymase
por: Hsieh, Justin T., et al.
Publicado: (2019)

Chymase inhibition protects diabetic rats from renal lesions
por: ZHANG, MEI, et al.
Publicado: (2016)

Measurement of carboxypeptidase R by colorimetric assay
por: Komura, H, et al.
Publicado: (2002)

Regulation of Chemerin Bioactivity by Plasma Carboxypeptidase N, Carboxypeptidase B (Activated Thrombin-activable Fibrinolysis Inhibitor), and Platelets
por: Du, Xiao-Yan, et al.
Publicado: (2009)

High-Density Lipoprotein Binds to Mycobacterium avium and Affects the Infection of THP-1 Macrophages
por: Ichimura, Naoya, et al.
Publicado: (2016)

Increased Bone Mass in Female Mice Lacking Mast Cell Chymase
por: Lind, Thomas, et al.
Publicado: (2016)

Chymase Inhibitor as a Novel Therapeutic Agent for Non-alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2018)

Chymase uptake by cardiomyocytes results in myosin degradation in cardiac volume overload
por: Powell, Pamela C., et al.
Publicado: (2019)

Chymase as a Possible Therapeutic Target for Amelioration of Non-Alcoholic Steatohepatitis
por: Takai, Shinji, et al.
Publicado: (2020)

Impact of early pericardial fluid chymase activation after cardiac surgery
por: Butts, Brittany, et al.
Publicado: (2023)

Regulation of dopamine transporter activity by carboxypeptidase E
por: Zhang, Heping, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_2rc90bofj7cb5b1q0juc9qe45c